Navigation Links
Erste Hundewelpen werden in einzigartiger Studie zur Allergieprävention behandelt
Date:6/12/2013

kt dazu in der Lage sein könnte, die breitgefächerte Immunstimulation zu replizieren, die durch unseren sauberen Lebensstil verloren gegangen ist.

Viktor Karlsson, CEO von Premune:

"Wir sind sehr froh darüber, dass unsere Studie auf so ein großes Teilnahmeinteresse stößt. Sie schwedischen Züchter engagieren sich wirklich sehr aktiv für das Wohlergehen ihrer Nachzucht und für Hunde im Allgemeinen. Wir freuen uns darauf, kontinuierlich mehr Welpen in die Studie einzubeziehen, wenn die nächsten Würfe auf die Welt kommen."

Johan Norgren, Züchter und Präsident des schwedischen Staffordshire-Bullterrier-Klubs:

"Wir kennen das Problem mit Allergien. Sie können auch Hunde betreffen, deren Eltern vollkommen gesund sind. Sobald wir von der Studie erfahren hatten, wollten wir daran teilnehmen. Die Besuche der Tierkrankenschwester sind reibungslos verlaufen, und die Hunde sind so lebhaft wie immer, nachdem sie die Tropfen erhalten haben. Sollte die Behandlung nachweislich die Entwicklung von Allergien verhindern, kann ich mir nicht vorstellen, dass Züchter ihre Welpen nicht damit behandeln wollen würden.

Weitere Informationen von:
Viktor Karlsson,
CEO, Premune
Telefon: +46(0)760265269
E-Mail: viktor@premune.com


'/>"/>
SOURCE Premune AB
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Erste Klage gegen Nobelpreis-Organisation wegen Verleumdung und unlauterem Wettbewerb eingereicht
2. Nominierungen für BRAVE Awards werden ab jetzt entgegengenommen
3. S*BIOs Novel JAK2 Inhibitor Pacritinib (SB1518) and Histone Deacetylase Inhibitor Pracinostat (SB939) Demonstrate Promising Activity in Phase 2 Studies for Patients with Myelofibrosis (MF)
4. Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease
5. Accelerate Brain Cancer Cure and Exosome Diagnostics Collaborate to Advance Clinical Studies of Exosome Biofluid Molecular Diagnostics Technology in Brain Cancer
6. Lupus Research Institute Awards $3.6 Million for Novel Studies Driving Wide-Ranging New Science in Lupus
7. EMD Millipore Partners with Charles River Laboratories for Improved Viral Clearance Studies
8. Novel compound halts tumor spread, improves brain cancer treatment in animal studies
9. Convergence Pharmaceuticals Announces Successful Completion of Phase I for CNV2197944 and Plans Phase II Studies in Neuropathic Pain
10. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
11. NIH Awards New England Biolabs a Phase II SBIR Grant for the Research and Development of Novel Enzymes for Epigenetic Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... PA (PRWEB) January 15, 2014 The Pittcon ... publisher of Food Safety Tech , an e-Journal and ... signed an agreement for the second year for the co-location ... Pittcon 2014. The partnership provides that the registration fee to ...
(Date:1/15/2014)... 2014 Cynvenio, a cancer diagnostics company ... genomic analysis of tumor cells in the bloodstream, today ... cancer decision support application powered by CollabRx, Inc. ... genomic test, Therapy Finder will provide breast cancer patients ...
(Date:1/15/2014)... 15, 2014 This webinar will focus ... clinical safety assessment in biosimilars. , Regulatory frameworks are ... drug development, however the complex nature of biopharmaceuticals makes ... and efficacy extremely challenging. Based on the specific aspects ...
(Date:1/15/2014)... VA (PRWEB) January 15, 2014 Two ... have continued their sponsorship of an annual competition for ... in, and access to, innovative STEM study. The competition ... TEAMS: Tests of Engineering Aptitude, Mathematics, and Sciences ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), a ... of peripheral vascular disease,announced today that it plans to ... 30, 2008, after the close of market on October ... teleconference at 2:00 p.m. PT,/ 5:00 p.m. ET on ...
... Cash On Hand and No Debt, NAPA, Calif., ... life sciences company engaged in the development,of technologies that ... company continues to maintain a strong, debt-free financial,position. Current ... Million,of which is invested in fully FDIC insured bank ...
... Die of Diabetes, BRUSSELS, October 13 The ... together key opinion,leaders to push for action to secure ... countries without access to care., The meeting, Access ... will be held on Saturday, October 25 in London, ...
Cached Biology Technology:VNUS Medical Technologies to Report Third-Quarter 2008 Results and Webcast Teleconference on October 29 2Senetek Affirms Strong Financial Position 2Senetek Affirms Strong Financial Position 3International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 2International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 3
(Date:4/23/2014)... of dementia and affects some 400,000 people in Spain ... One of the reasons for this is the lack ... in nerve transmissions and the loss of memory in ... Institute of Neuroscience at the Universitat Autnoma de Barcelona ... and were able to develop a gene therapy which ...
(Date:4/23/2014)... is leading a 2 million Food Standards Agency (FSA) ... premises and industry workers. , Norovirus outbreaks can ... a batch of frozen strawberries infected 11,000 people in ... understanding of which strains cause infection and which foods ... , Researchers will produce data that will help ...
(Date:4/22/2014)... of Montana,s Wildlife Biology Program, co-wrote a research paper published ... of Sciences on how streamwater chemistry varies across a ... Lowe and co-authors from ... the Cary Institute of Ecosystem Studies, the University of Connecticut ... water samples collected every 10 meters along 32 tributaries of ...
Breaking Biology News(10 mins):Loss of memory in Alzheimer's mice models reversed through gene therapy 2New research focuses on streamwater chemistry, landscape variation 2
... , LAKE MARY, Fla. , April 26 Roundtable Concepts ... are of the highest quality components and specifications. A great review has been ... limited time only, is offering this promotional special: the RTC View 32" LCD ... at www.rtcview.com . , , ...
... 26 Kevin Harvick and the Shell-Pennzoil ... in a NASCAR Sprint Cup Series points-scoring race.  The Shell-Pennzoil ... Aaron,s 499 at Talladega Superspeedway where Harvick made a last-lap ... just 0.011 seconds to spare.  The finish was the eighth ...
... , April 26 Desarrolladora Homex,S.A.B. de C.V. ("Homex" or ... Quarter ended on March 31, 2010 (1). , ... As previously stated, effective ... Homex recognizes its revenues, costs and expenses when the,Company has transferred the ...
Cached Biology News:Roundtable Concepts Inc., the Company that has Officially Licensed Marvel Comic TVs and Officially Licensed Collegiate TVs, has just Launched their Own Line of HDTVs Named RTC View 2Harvick Breaks 115-Race Winless Streak To Take the Checkered Flag in Dramatic Finish at Talladega 2Harvick Breaks 115-Race Winless Streak To Take the Checkered Flag in Dramatic Finish at Talladega 3Harvick Breaks 115-Race Winless Streak To Take the Checkered Flag in Dramatic Finish at Talladega 4Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 2Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 3Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 4Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 5Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 6Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 7Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 8
Anti-Chicken IgY, (IgG) F(ab')2 Fragment Specific....
Presenilin 2 Immunogen: Synthetic peptide corresponding to residues 31-47 of human Presenilin 2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Recognizes TWIK-2. Does not cross react with any other known proteins....
Sheep polyclonal to ErbB 2 ( Abpromise for all tested applications). Antigen: Recombinant full length c-ErbB2 protein (Human). Entrez GeneID: 2064 Swiss Protein ID: P04626...
Biology Products: